Randomized study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Pre‐specified analysis of the Chinese population from the BERSON clinical trial

AIM: The aim of this study was to evaluate the efficacy and safety of evolocumab with background atorvastatin in Chinese patients with type 2 diabetes mellitus (T2DM) and hyperlipidaemia or mixed dyslipidaemia. MATERIALS AND METHODS: This is a pre‐specified analysis of patients in the BERSON study (...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yundai, Yuan, Zuyi, Lu, Juming, Eliaschewitz, Freddy G., Lorenzatti, Alberto J., Monsalvo, Maria Laura, Wang, Nan, Hamer, Andrew W., Ge, Junbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594089/
https://www.ncbi.nlm.nih.gov/pubmed/30851062
http://dx.doi.org/10.1111/dom.13700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594089/
https://www.ncbi.nlm.nih.gov/pubmed/30851062
http://dx.doi.org/10.1111/dom.13700

Ejemplares similares